ARTICLE
13 March 2020

FDA User Fee Agreements (Video)

M
Mintz

Contributor

Mintz logo
Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Explore Firm Details
In this video, Aaron Josephson discusses FDA user fee agreements, the timeline for the reauthorization process, and why it is important for companies with FDA-regulated products to be paying attention now.
United States Food, Drugs, Healthcare, Life Sciences
Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C
Your Author LinkedIn Connections

In this video, Aaron Josephson discusses FDA user fee agreements, the timeline for the reauthorization process, and why it is important for companies with FDA-regulated products to be paying attention now.

February 14, 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Authors
Person photo placeholder
Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C
Your Author LinkedIn Connections
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More